Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamis Pharmaceuticals
Adamis Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Symjepi
Epinephrine
2017-06-15
2024-2039
Airway obstruction
,
Anaphylaxis
,
Bradycardia
,
Bronchial spasm
,
Heart arrest
,
Heart block
,
Hypotension
,
Open-angle glaucoma
,
Septic shock
,
Ventricular fibrillation
,
Ventricular tachycardia
Zimhi
Naloxone
2021-10-15
2024-2041
Opioid-related disorders
,
Respiration disorders
,
Septic shock
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aglatimagene besadenovec
prostatic neoplasms
Tempol
covid-19
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use